Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published March 1, 2003 | Published
Journal Article Open

Orbit/Mast, the CLASP orthologue of Drosophila, is required for asymmetric stem cell and cystocyte divisions and development of the polarised microtubule network that interconnects oocyte and nurse cells during oogenesis

Abstract

Drosophila oocyte differentiation is preceded by the formation of a polarised 16-cell cyst from a single progenitor stem cell as a result of four rounds of asymmetric mitosis followed by incomplete cytokinesis. We show that the Orbit/Mast microtubule-associated protein is required at several stages in the formation of such polarised 16-cell cysts. In wild-type cysts, the Orbit/Mast protein not only associates with the mitotic spindle and its poles, but also with the central spindle (spindle remnant), ring canal and fusome, suggesting it participates in interactions between these structures. In orbit mutants, the stem cells and their associated fusomes are eventually lost as Orbit/Mast protein is depleted. The mitotic spindles of those cystocytes that do divide are either diminutive or monopolar, and do not make contact with the fusome. Moreover, the spindle remnants and ring canals fail to differentiate correctly in such cells and the structure of fusome is compromised. The Orbit/Mast protein thus appears to facilitate multiple interactions of the fusome with mitotic spindles and ring canals. This ensures correct growth of the fusome into a branched asymmetrically distributed organelle that is pre-determinative of 16-cell cyst formation and oocyte fate specification. Finally the Orbit/Mast protein is required during mid-oogenesis for the organisation of the polarised microtubule network inside the 16-cell cyst that ensures oocyte differentiation. The localisation of CLIP-190 to such microtubules and to the fusome is dependent upon Orbit/Mast to which it is complexed.

Additional Information

© 2003 The Company of Biologists Ltd. Accepted November 29, 2002. Published online March 1, 2003. We are grateful to Alfonso Martinez-Arias, Matthew Savoian, Joseph Laycock and Marisa Segal for stimulating discussions. We would like to thank Kathryn Miller for the anti-CLIP-190; Lynn Cooley for the anti-Filamin, anti-HtsRC and anti-Kelch; and Christine Field for the anti-anillin. The monoclonal antibody 1B1 developed by Howard Lipshitz was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa. This work was supported by a grant from Cancer Research UK to D. M. G.

Attached Files

Published - 901.full.pdf

Files

901.full.pdf
Files (4.8 MB)
Name Size Download all
md5:5e16555cb17ede425046f9e4aabd7674
4.8 MB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 20, 2023